US FDA places clinical hold on Tenaya gene therapy trial for rare heart disease

Tenaya Therapeutics said on Friday the U. Food and Drug Administration has ​placed a clinical hold on its trial of an ...
MedPage Today on MSN

ACR Issues First Update to Lupus Guideline Since 1999

Long-awaited updates to the American College of Rheumatology's (ACR) guideline on systemic lupus erythematosus (SLE) ...
The Scientist

Extending Transplant Life Through Targeted Innovation

Organ transplantation is fraught with challenges, from donor shortages to eventual transplanted organ failure. The immunosuppressive drugs that are currently the standard of care following ...
Medpage Today on MSN

GLP-1 Agonists Tied to Lower Risk of Death in Dialysis Patients

Among over 151,000 patients, use of GLP-1 drugs was linked to a lower risk of death compared with no use (adjusted HR 0.77, 95% CI 0.70-0.85, P <0.001), reported Babak J. Orandi, MD, PhD, MSc, of NYU ...
PharmiWeb

Adaptam Therapeutics raises €3 million to pioneer cancer immunotherapies against immunosuppressive myeloid cells

Financing round, led by founding investor Criteria Bio Ventures, will enable Adaptam to advance first-in-class antibody-based therapies, including antibody-drug conjugates (ADCs) and bispecific ...
Medscape

Patient Decision Aid for SLE Improves Care and Outcomes

The implementation of a decision aid for systemic lupus erythematosus (SLE) in US clinics improved patient outcomes, including reduced decisional conflict and enhanced shared decision-making. Over 80% ...